As part of the IDDO platform, WWARN works in partnership with multiple organisations to share knowledge, expertise and understanding on the efficacy of malaria drugs.
Assessing the efficacy of a range of antimalarials used for the treatment of P. falciparum malaria in all trimesters of pregnancy in Africa and Asia. The MiP Treatment Efficacy Study Group was formed in July 2016, with a call to interested researchers with relevant data sets.
A pooled analysis on the relationship between K13 molecular marker and parasite clearance data. The Study Group closed to new participants in December 2015 . The Study Group closed to new participants in December 2015. Data analysis and manuscript drafting is currently ongoing and expected to be shared with Study Group members by April 2017. Publication submission is planned for Q3 2017.
A pooled analysis assessing the effect of various nutritional indicators in treatment outcome in children aged 6-59 months treated with artemisinin based combination therapies for uncomplicated P. falciparum malaria.
This study group has now closed to new data contributions. A detailed Statistical Analysis Plan is available to Study Group members, with statistical analysis ongoing. Results and draft publication are expected by Q2 of 2017.
Sharing and pooling data is supporting global efforts to curb the spread of malaria drug resistance. See examples of our data sharing tools, and how you can benefit from joining our data sharing efforts.
Partnerships play a critical role in WWARN’s efforts to combat antimalarial drug resistance. Find out more about the international research projects we are supporting.